{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T20:24:54Z","timestamp":1782591894861,"version":"3.54.5"},"reference-count":39,"publisher":"BMJ","license":[{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To examine associations between birth defects and cancer from birth into adulthood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Population based nested case-control study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Nationwide health registries in Denmark, Finland, Norway, and Sweden.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>62\u2009295 cancer cases (0-46 years) and 724\u2009542 frequency matched controls (matched on country and birth year), born between 1967 and 2014.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>Relative risk of cancer in relation to major birth defects, estimated as odds ratios with 99% confidence intervals from logistic regression models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Altogether, 3.5% (2160\/62\u2009295) of cases and 2.2% (15\u2009826\/724\u2009542) of controls were born with major birth defects. The odds ratio of cancer for people with major birth defects compared with those without was 1.74 (99% confidence interval 1.63 to 1.84). For individuals with non-chromosomal birth defects, the odds ratio of cancer was 1.54 (1.44 to 1.64); for those with chromosomal anomalies, the odds ratio was 5.53 (4.67 to 6.54). Many structural birth defects were associated with later cancer in the same organ system or anatomical location, such as defects of the eye, nervous system, and urinary organs. The odds ratio of cancer increased with number of defects and decreased with age, for both non-chromosomal and chromosomal anomalies. The odds ratio of cancer in people with any non-chromosomal birth defect was lower in adults (\u226520 years: 1.21, 1.09 to 1.33) than in adolescents (15-19 years: 1.58, 1.31 to 1.90) and children (0-14 years: 2.03, 1.85 to 2.23). The relative overall cancer risk among adults with chromosomal anomalies was markedly reduced from 11.3 (9.35 to 13.8) in children to 1.50 (1.01 to 2.24). Among adults, skeletal dysplasia (odds ratio 3.54, 1.54 to 8.15), nervous system defects (1.76, 1.16 to 2.65), chromosomal anomalies (1.50, 1.01 to 2.24), genital organs defects (1.43, 1.14 to 1.78), and congenital heart defects (1.28, 1.02 to 1.59) were associated with overall cancer risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The increased risk of cancer in individuals with birth defects persisted into adulthood, both for non-chromosomal and chromosomal anomalies. Further studies on the molecular mechanisms involved are warranted.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmj.m4060","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T05:00:36Z","timestamp":1606971636000},"page":"m4060","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":30,"title":["Cancer risk in individuals with major birth defects: large Nordic population based case-control study among children, adolescents, and adults"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0903-1140","authenticated-orcid":false,"given":"Dagrun Sletteb\u00f8","family":"Daltveit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Klungs\u00f8yr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Engeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Ekbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Gissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Glimelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Grotmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Madanat-Harjuoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Gulbech","family":"Ording","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solbj\u00f8rg Makalani Myrtveit","family":"S\u00e6ther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Troisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tone","family":"Bj\u00f8rge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,12,2]]},"reference":[{"key":"2020120221100482000_371.dec02_9.m4060.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30339-0"},{"key":"2020120221100482000_371.dec02_9.m4060.2","unstructured":"EUROCAT. Prevalence charts and tables. 2020. https:\/\/eu-rd-platform.jrc.ec.europa.eu\/eurocat\/eurocat-data\/prevalence_en."},{"key":"2020120221100482000_371.dec02_9.m4060.3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1215"},{"key":"2020120221100482000_371.dec02_9.m4060.4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181246"},{"key":"2020120221100482000_371.dec02_9.m4060.5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179006"},{"key":"2020120221100482000_371.dec02_9.m4060.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2014.09.013"},{"key":"2020120221100482000_371.dec02_9.m4060.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2249"},{"key":"2020120221100482000_371.dec02_9.m4060.8","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-2630"},{"key":"2020120221100482000_371.dec02_9.m4060.9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20985"},{"key":"2020120221100482000_371.dec02_9.m4060.10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069077"},{"key":"2020120221100482000_371.dec02_9.m4060.11","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwr470"},{"key":"2020120221100482000_371.dec02_9.m4060.12","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23364"},{"key":"2020120221100482000_371.dec02_9.m4060.13","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23494"},{"key":"2020120221100482000_371.dec02_9.m4060.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2014.04.001"},{"key":"2020120221100482000_371.dec02_9.m4060.15","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1207"},{"key":"2020120221100482000_371.dec02_9.m4060.16","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.12302"},{"key":"2020120221100482000_371.dec02_9.m4060.17","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S91125"},{"key":"2020120221100482000_371.dec02_9.m4060.18","unstructured":"Ritvanen A . Ep\u00e4muodostumat 1993-2011 \u2013 Congenital anomalies 1993-2011. National Institute for Health and Welfare in Finland, 2014."},{"key":"2020120221100482000_371.dec02_9.m4060.19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-450"},{"key":"2020120221100482000_371.dec02_9.m4060.20","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2017.1407039"},{"key":"2020120221100482000_371.dec02_9.m4060.21","unstructured":"World Health Organization. International classification of diseases for oncology (ICD-O) \u2013 3rd edition, 1st revision, 3rd ed. 2013. https:\/\/apps.who.int\/iris\/handle\/10665\/96612."},{"key":"2020120221100482000_371.dec02_9.m4060.22","unstructured":"World Health Organization. International statistical classification of diseases and related health problems, 10th revision, Fifth edition, 2016. 2015. https:\/\/apps.who.int\/iris\/handle\/10665\/246208."},{"key":"2020120221100482000_371.dec02_9.m4060.23","unstructured":"Socialstyrelsen. Kodning i cancerregistret 2017. 2016. Available from: https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/artikelkatalog\/statistik\/2016-12-9.pdf."},{"key":"2020120221100482000_371.dec02_9.m4060.24","unstructured":"Cancer Registry of Norway . Cancer in Norway 2017 - Cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway, 2018."},{"key":"2020120221100482000_371.dec02_9.m4060.25","unstructured":"NORDCAN. Comparable cancer statistics for Denmark, Finland, Iceland, Norway, Sweden, the Faroe Islands, and Greenland. https:\/\/nordcan.iarc.fr\/en."},{"key":"2020120221100482000_371.dec02_9.m4060.26","unstructured":"EUROCAT . EUROCAT Guide 1.4: Instruction for the registration of congenital anomalies. EUROCAT Central Registry. University of Ulster, 2013."},{"key":"2020120221100482000_371.dec02_9.m4060.27","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20777"},{"key":"2020120221100482000_371.dec02_9.m4060.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i969"},{"key":"2020120221100482000_371.dec02_9.m4060.29","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/11.6.1269"},{"key":"2020120221100482000_371.dec02_9.m4060.30","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/22.6.1189"},{"key":"2020120221100482000_371.dec02_9.m4060.31","unstructured":"Mitchell MN . Interpreting and Visualizing Regression Models Using Stata. Stata Press, 2012: 558."},{"key":"2020120221100482000_371.dec02_9.m4060.32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-96"},{"key":"2020120221100482000_371.dec02_9.m4060.33","doi-asserted-by":"publisher","DOI":"10.1080\/08037050701645090"},{"key":"2020120221100482000_371.dec02_9.m4060.34","doi-asserted-by":"publisher","DOI":"10.1080\/00016340802217184"},{"key":"2020120221100482000_371.dec02_9.m4060.35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.6762"},{"key":"2020120221100482000_371.dec02_9.m4060.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.08.057"},{"key":"2020120221100482000_371.dec02_9.m4060.37","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22373"},{"key":"2020120221100482000_371.dec02_9.m4060.38","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21518"},{"key":"2020120221100482000_371.dec02_9.m4060.39","unstructured":"NORDCAN. Incidence, Males, in 2016: All sites. https:\/\/nordcan.iarc.fr\/en\/dataviz\/tables."}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.m4060","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.m4060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T05:11:25Z","timestamp":1606972285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.m4060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,2]]},"references-count":39,"alternative-id":["10.1136\/bmj.m4060"],"URL":"https:\/\/doi.org\/10.1136\/bmj.m4060","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,2]]}}}